Progression of Physical Frailty and the Risk of All-Cause Mortality: Is There a Point of No Return?
Aged
Cause of Death
Clinical Decision Rules
Clinical Deterioration
Disease Progression
Female
Frail Elderly
Frailty
/ diagnosis
Geriatric Assessment
/ methods
Humans
Independent Living
/ statistics & numerical data
Male
Mortality
Palliative Care
/ methods
Residential Facilities
/ statistics & numerical data
Risk Assessment
/ methods
Risk Factors
aging phenotype
comorbidity
critical transition
palliative care
vulnerability
Journal
Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
revised:
04
11
2020
received:
07
08
2020
accepted:
19
11
2020
pubmed:
29
12
2020
medline:
24
9
2021
entrez:
28
12
2020
Statut:
ppublish
Résumé
To investigate the rate and patterns of accumulation of frailty manifestations in relationship to all-cause mortality and whether there is a point in the progression of frailty beyond which the process becomes irreversible and death becomes imminent (a.k.a. point of no return). Longitudinal observational study. Community or a non-nursing home residential care setting. Two thousand five hundred and fifty seven robust older adults identified at baseline in 2011 with follow-up for all-cause mortality between 2011 and 2018. Frailty was measured by the physical frailty phenotype. Cox models were used to study the relationships of the number of frailty criteria (0-5) at each point in time and its accumulation patterns with all-cause mortality. Markov state-transition models were used to study annual transitions between health states (i.e., frailty, recovery, and death) after becoming frail among those with frailty onset (n = 373). There was a nonlinear association between greater number of frailty criteria and increasing risk of mortality, with a notable risk acceleration after having accumulated all five criteria (hazard ratio (HR) = 32.6 vs none, 95% confidence interval (CI) = 15.7-67.5). In addition, the risk of one-year mortality tripled, and the likelihood of recovery (i.e., reverting to be robust or pre-frail) halved among those with five frailty criteria compared to those with three or four criteria. A 50% increase in mortality risk was also associated with frailty onset without (vs with) a prior history of pre-frailty (HR = 1.51, 95% CI = 1.20-1.90). Both the number and rate of accumulation of frailty criteria were associated with mortality risk. Although there was insufficient evidence to declare a point of no return, having all five-frailty criteria signals the beginning of a transition toward a point of no return. Ongoing monitoring of frailty progression could aid clinical and personal decision-making regarding timing of intervention and eventual transition from curative to palliative care.
Identifiants
pubmed: 33368158
doi: 10.1111/jgs.16976
pmc: PMC8049969
mid: NIHMS1662820
doi:
Types de publication
Journal Article
Observational Study
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
908-915Subventions
Organisme : NIA NIH HHS
ID : P30 AG021334
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG032947
Pays : United States
Organisme : NIA NIH HHS
ID : U01AG032947
Pays : United States
Organisme : NIA NIH HHS
ID : P30AG021334
Pays : United States
Informations de copyright
© 2020 The American Geriatrics Society.
Références
J Gerontol A Biol Sci Med Sci. 2016 Apr;71(4):489-95
pubmed: 26718984
Ageing Res Rev. 2016 Mar;26:53-61
pubmed: 26674984
J Am Coll Surg. 2010 Jun;210(6):901-8
pubmed: 20510798
J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):731-7
pubmed: 17634320
Science. 2012 Oct 19;338(6105):344-8
pubmed: 23087241
Sci Aging Knowledge Environ. 2005 Aug 03;2005(31):pe24
pubmed: 16079413
J Gerontol A Biol Sci Med Sci. 2019 Apr 23;74(5):667-674
pubmed: 30084927
J Gerontol B Psychol Sci Soc Sci. 2018 Apr 16;73(4):564-572
pubmed: 28977651
J Gerontol A Biol Sci Med Sci. 2015 Nov;70(11):1427-34
pubmed: 26297656
J Am Geriatr Soc. 2017 Jan;65(1):179-184
pubmed: 27861714
Eur J Intern Med. 2017 Nov;45:84-90
pubmed: 28993099
Curr Geriatr Rep. 2019 Jun;8(2):97-106
pubmed: 31815092
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
BMJ Support Palliat Care. 2015 Dec;5(4):335-42
pubmed: 26586682
J Am Med Dir Assoc. 2013 Jun;14(6):392-7
pubmed: 23764209
Clin Geriatr Med. 2011 Feb;27(1):1-15
pubmed: 21093718
J Gerontol A Biol Sci Med Sci. 2006 Mar;61(3):262-6
pubmed: 16567375
Arch Surg. 2012 Feb;147(2):190-3
pubmed: 22351919
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
J Gerontol A Biol Sci Med Sci. 2008 Sep;63(9):984-90
pubmed: 18840805
Am J Transplant. 2013 Aug;13(8):2091-5
pubmed: 23731461
J Gerontol B Psychol Sci Soc Sci. 2014 Nov;69 Suppl 1:S1-7
pubmed: 25342818